Mindray Medical International (MR) Tops Q4 EPS by 7c; Issues FY13 Outlook

February 25, 2013 5:02 PM EST
Mindray Medical International (NYSE: MR) reported Q4 EPS of $0.51, $0.07 better than the analyst estimate of $0.44. Revenue for the quarter came in at $316.1 million versus the consensus estimate of $309.3 million.

The company expects its full year 2013 net revenues to grow at least 17% over its full year 2012 net revenues. The company also expects its full year 2013 non-GAAP net income to grow at least 15% over its non-GAAP net income for the full year 2012. This guidance excludes the tax benefits related to the key software enterprise status for the calendar year 2011 and 2012 that we may receive in 2013 and assumes a corporate income tax rate of 15% applicable to the Shenzhen subsidiary.

For earnings history and earnings-related data on Mindray Medical International (MR) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment